Maiva Pharma

Maiva Pharma is a CMO/CDMO focused on sterile injections in India. In June 2026, a new 22-acre plant was opened in Shoolagiri, Tamil Nadu, with six production lines planned; the first phase has been put into production with a high-speed vial line, a combined PFS and cartridge line, and a freeze-drying line, all using isolator technology. Dosage forms cover vials, PFS, cassettes, suspensions and freeze-dried formulations for the global regulated market. The plant was built in accordance with international regulatory standards, strengthening the contract manufacturing capacity of aseptic injections and complex drug delivery systems in India.